비소세포폐암 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "비소세포폐암" in Korean language version.

refsWebsite

Global rank Korean rank

30doi.org

2^nd place

3^rd place

25nih.gov

4^th place

7semanticscholar.org

11^th place

310^th place

6web.archive.org

1^st place

5worldcat.org

5^th place

11^th place

4cancer.org

3,680^th place

3,568^th place

4cancer.gov

1,684^th place

647^th place

2medscape.com

719^th place

424^th place

1wikimedia.org

low place

1iarc.fr

4,025^th place

1,731^st place

1archive.today

14^th place

15^th place

1chestjournal.org

low place

1umm.edu

9,624^th place

3,051^st place

1cancerstaging.org

low place

1nccn.org

low place

1cancerhelp.org.uk

low place

1lungcanceronline.org

low place

1mycancergenome.org

low place

1genengnews.com

low place

1ascopubs.org

low place

1fda.gov

447^th place

433^rd place

1businesswire.com

615^th place

1,789^th place

archive.today

Simon GR, Turrisi A (September 2007). “Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)”. 《Chest》 132 (3 Suppl): 324S–339S. doi:10.1378/chest.07-1385. PMID 17873178. 2013년 1월 12일에 원본 문서에서 보존된 문서.

ascopubs.org

Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, 외. (March 2019). “Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater”. 《Journal of Clinical Oncology》 37 (7): 537–546. doi:10.1200/JCO.18.00149. PMID 30620668. S2CID 58640902.

businesswire.com

“Takeda's Exkivity (mobocertinib) Approved by U.S. FDA as the First Oral Therapy Specifically Designed for Patients with EGFR Exon20 Insertion+ NSCLC” (보도 자료). Takeda. 2021년 9월 15일. 2021년 9월 16일에 확인함 – Business Wire 경유.

cancer.gov

“Non-Small Cell Lung Cancer Treatment”. 《National Cancer Institute》 (영어). 1980년 1월 1일. 2017년 12월 4일에 확인함.
“Non-small cell lung cancer treatment – National Cancer Institute”. 1980년 1월 1일. 2008년 10월 19일에 확인함.
“Non-Small Cell Lung Cancer Treatment”. 《National Cancer Institute》 (영어). 1980년 1월 1일. 2017년 12월 4일에 확인함.
“National Cancer Institute Non-Small Cell Lung Cancer Treatment (PDQ)”. 1980년 1월 1일. 2015년 5월 12일에 확인함.

cancer.org

“What Is Non-Small Cell Lung Cancer?”. 《www.cancer.org》. 2017년 1월 17일에 원본 문서에서 보존된 문서. 2023년 9월 13일에 확인함.
“Non-Small Cell Lung Cancer Signs and Symptoms”. 《www.cancer.org》. 2017년 12월 4일에 확인함.
“Non-Small Cell Lung Cancer Risk Factors”. 《www.cancer.org》. 2016년 12월 7일에 원본 문서에서 보존된 문서. 2023년 9월 13일에 확인함.
“Non-Small Cell Lung Cancer Survival Rates, by Stage”. 《www.cancer.org》. 2017년 12월 4일에 확인함.

cancerhelp.org.uk

“Chemoembolisation”. Cancer Research UK. 2017년 8월 30일. 2007년 10월 9일에 원본 문서에서 보존된 문서.

cancerstaging.org

〈Cancer Staging Posters: Lung〉 (PDF). 《AJCC Cancer Staging》 7판. 2009. 2011년 9월 28일에 원본 문서 (PDF)에서 보존된 문서.

chestjournal.org

Simon GR, Turrisi A (September 2007). “Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)”. 《Chest》 132 (3 Suppl): 324S–339S. doi:10.1378/chest.07-1385. PMID 17873178. 2013년 1월 12일에 원본 문서에서 보존된 문서.

doi.org

dx.doi.org

Khajuria, Ocean; Sharma, Neha (2021년 12월 1일). “Epigenetic targeting for lung cancer treatment via CRISPR/Cas9 technology”. 《Advances in Cancer Biology - Metastasis》 (영어) 3: 100012. doi:10.1016/j.adcanc.2021.100012. ISSN 2667-3940. S2CID 241848193.
Smokers defined as current or former smoker of more than 1 year of duration. See image page in Commons for percentages in numbers. Reference: Table 2 in: Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA (June 2008). “Comparison of aspects of smoking among the four histological types of lung cancer”. 《Tobacco Control》 17 (3): 198–204. doi:10.1136/tc.2007.022582. PMC 3044470. PMID 18390646.
Simon GR, Turrisi A (September 2007). “Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)”. 《Chest》 132 (3 Suppl): 324S–339S. doi:10.1378/chest.07-1385. PMID 17873178. 2013년 1월 12일에 원본 문서에서 보존된 문서.
Subramanian J, Govindan R (February 2007). “Lung cancer in never smokers: a review”. 《Journal of Clinical Oncology》 25 (5): 561–70. doi:10.1200/JCO.2006.06.8015. PMID 17290066.
Travis WD, Travis LB, Devesa SS (January 1995). “Lung cancer”. 《Cancer》 75 (1 Suppl): 191–202. doi:10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y. PMID 8000996. S2CID 221577784.
Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA (June 2008). “Comparison of aspects of smoking among the four histological types of lung cancer”. 《Tobacco Control》 17 (3): 198–204. doi:10.1136/tc.2007.022582. PMC 3044470. PMID 18390646.
Popper HH (2011). “Large cell carcinoma of the lung – a vanishing entity?”. 《Memo - Magazine of European Medical Oncology》 4: 4–9. doi:10.1007/s12254-011-0245-8. S2CID 71238993.
Liu X, Conner H, Kobayashi T, Kim H, Wen F, Abe S, 외. (August 2005). “Cigarette smoke extract induces DNA damage but not apoptosis in human bronchial epithelial cells”. 《American Journal of Respiratory Cell and Molecular Biology》 33 (2): 121–9. doi:10.1165/rcmb.2003-0341OC. PMID 15845867.
Khajuria, Ocean; Sharma, Neha (2021년 12월 1일). “Epigenetic targeting for lung cancer treatment via CRISPR/Cas9 technology”. 《Advances in Cancer Biology - Metastasis》 (영어) 3: 100012. doi:10.1016/j.adcanc.2021.100012. ISSN 2667-3940. S2CID 241848193.
Khajuria, Ocean; Sharma, Neha (2021년 12월 1일). “Epigenetic targeting for lung cancer treatment via CRISPR/Cas9 technology”. 《Advances in Cancer Biology - Metastasis》 (영어) 3: 100012. doi:10.1016/j.adcanc.2021.100012. ISSN 2667-3940. S2CID 241848193.
Herbst, Roy S.; Heymach, John V.; Lippman, Scott M. (2008년 9월 25일). “Lung Cancer”. 《New England Journal of Medicine》 359 (13): 1367–1380. doi:10.1056/NEJMra0802714. ISSN 0028-4793. PMID 18815398. S2CID 33554415.
Kastan MB (April 2008). “DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture”. 《Molecular Cancer Research》 6 (4): 517–24. doi:10.1158/1541-7786.MCR-08-0020. PMID 18403632.
O'Hagan HM, Mohammad HP, Baylin SB (August 2008). Lee JT, 편집. “Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island”. 《PLOS Genetics》 4 (8): e1000155. doi:10.1371/journal.pgen.1000155. PMC 2491723. PMID 18704159.
Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, 외. (July 2007). “DNA damage, homology-directed repair, and DNA methylation”. 《PLOS Genetics》 3 (7): e110. doi:10.1371/journal.pgen.0030110. PMC 1913100. PMID 17616978.
Harper JW, Elledge SJ (December 2007). “The DNA damage response: ten years after”. 《Molecular Cell》 28 (5): 739–45. doi:10.1016/j.molcel.2007.11.015. PMID 18082599.
Chawla M, Kumar R, Agarwala S, Bakhshi S, Gupta DK, Malhotra A (October 2010). “Role of positron emission tomography-computed tomography in staging and early chemotherapy response evaluation in children with neuroblastoma”. 《Indian Journal of Nuclear Medicine》 25 (4): 147–55. doi:10.4103/0972-3919.78249. PMC 3109821. PMID 21713223.
Dupuy DE, Shulman M (September 2010). “Current status of thermal ablation treatments for lung malignancies”. 《Seminars in Interventional Radiology》 27 (3): 268–75. doi:10.1055/s-0030-1261785. PMC 3324195. PMID 22550366.
Bargellini I, Bozzi E, Cioni R, Parentini B, Bartolozzi C (October 2011). “Radiofrequency ablation of lung tumours”. 《Insights into Imaging》 2 (5): 567–576. doi:10.1007/s13244-011-0110-7. PMC 3259330. PMID 22347976.
Kwan SW, Mortell KE, Talenfeld AD, Brunner MC (January 2014). “Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer”. 《Journal of Vascular and Interventional Radiology》 25 (1): 1–9.e1. doi:10.1016/j.jvir.2013.10.018. PMID 24365502.
Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE (July 2006). “Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer”. 《Journal of Vascular and Interventional Radiology》 17 (7): 1117–24. doi:10.1097/01.RVI.0000228373.58498.6E. PMID 16868164.
Vasconcellos, Vitor F.; Marta, Guilherme N.; da Silva, Edina Mk; Gois, Aecio Ft; de Castria, Tiago B.; Riera, Rachel (2020년 1월 13일). “Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer”. 《The Cochrane Database of Systematic Reviews》 1 (1): CD009256. doi:10.1002/14651858.CD009256.pub3. ISSN 1469-493X. PMC 6956680. PMID 31930743.
Ferrara, Roberto; Imbimbo, Martina; Malouf, Reem; Paget-Bailly, Sophie; Calais, François; Marchal, Corynne; Westeel, Virginie (2021년 4월 30일). “Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer”. 《Cochrane Database of Systematic Reviews》 2021 (4): CD013257. doi:10.1002/14651858.CD013257.pub3. PMC 8092423. PMID 33930176.
Yang ZY, Liu L, Mao C, Wu XY, Huang YF, Hu XF, Tang JL (November 2014). “Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer”. 《The Cochrane Database of Systematic Reviews》 (11): CD009948. doi:10.1002/14651858.CD009948.pub2. PMID 25400254.
Hirsch FR, Bunn PA (May 2009). “EGFR testing in lung cancer is ready for prime time”. 《The Lancet. Oncology》 10 (5): 432–3. doi:10.1016/s1470-2045(09)70110-x. PMID 19410185.
Kris MG (October 2005). “How today's developments in the treatment of non-small cell lung cancer will change tomorrow's standards of care”. 《The Oncologist》. 10 Suppl 2 (Suppl 2): 23–9. doi:10.1634/theoncologist.10-90002-23. PMID 16272456.
Sherwood J, Dearden S, Ratcliffe M, Walker J (September 2015). “Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review”. 《Journal of Experimental & Clinical Cancer Research》 34 (1): 92. doi:10.1186/s13046-015-0207-9. PMC 4559261. PMID 26338018.
Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, 외. (December 2006). “Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer”. 《The New England Journal of Medicine》 355 (24): 2542–50. doi:10.1056/nejmoa061884. PMID 17167137.
Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, 외. (November 2016). “Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer”. 《The New England Journal of Medicine》 375 (19): 1823–1833. doi:10.1056/NEJMoa1606774. PMID 27718847.
Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, 외. (March 2019). “Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater”. 《Journal of Clinical Oncology》 37 (7): 537–546. doi:10.1200/JCO.18.00149. PMID 30620668. S2CID 58640902.

doi.org

Herbst, Roy S.; Heymach, John V.; Lippman, Scott M. (2008년 9월 25일). “Lung Cancer”. 《New England Journal of Medicine》 359 (13): 1367–1380. doi:10.1056/NEJMra0802714. ISSN 0028-4793. PMID 18815398. S2CID 33554415.

fda.gov

“FDA grants accelerated approval to mobocertinib for metastatic non-sma”. 《U.S. Food and Drug Administration (FDA)》. 2021년 9월 16일. 2021년 9월 16일에 확인함. 이 문서는 퍼블릭 도메인 출처의 본문을 포함합니다.

genengnews.com

Farmer (2010). “Non-Small-Cell Lung Cancer Standards of Care Challenged by a Cornucopia of New Drugs”.

iarc.fr

Travis, William D; Brambilla, Elisabeth; Muller-Hermelink, H Konrad; 외., 편집. (2004). 《Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart》 (PDF). World Health Organization Classification of Tumours. Lyon: IARC Press. ISBN 978-92-832-2418-1. 2009년 8월 23일에 원본 문서 (PDF)에서 보존된 문서. 2010년 3월 27일에 확인함.

lungcanceronline.org

“Lung Cancer online”. 《lungcanceronline.org》. 2008년 6월 17일에 원본 문서에서 보존된 문서. 2008년 12월 13일에 확인함.

medscape.com

emedicine.medscape.com

Non-Small Cell Lung Cancer - eMedicine

medscape.com

Hanna N (2007). “Lung Cancer in the Never Smoker Population”. 《Hematology-Oncology》. Medscape.

mycancergenome.org

“Molecular Profiling of Lung Cancer”. 2015년 5월 12일에 확인함.

nccn.org

“NCCN Clinical Practice Guidelines for NSCLC” (PDF). 2015년 5월 12일에 확인함.

nih.gov

ncbi.nlm.nih.gov

Smokers defined as current or former smoker of more than 1 year of duration. See image page in Commons for percentages in numbers. Reference: Table 2 in: Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA (June 2008). “Comparison of aspects of smoking among the four histological types of lung cancer”. 《Tobacco Control》 17 (3): 198–204. doi:10.1136/tc.2007.022582. PMC 3044470. PMID 18390646.
Simon GR, Turrisi A (September 2007). “Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)”. 《Chest》 132 (3 Suppl): 324S–339S. doi:10.1378/chest.07-1385. PMID 17873178. 2013년 1월 12일에 원본 문서에서 보존된 문서.
Subramanian J, Govindan R (February 2007). “Lung cancer in never smokers: a review”. 《Journal of Clinical Oncology》 25 (5): 561–70. doi:10.1200/JCO.2006.06.8015. PMID 17290066.
Travis WD, Travis LB, Devesa SS (January 1995). “Lung cancer”. 《Cancer》 75 (1 Suppl): 191–202. doi:10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y. PMID 8000996. S2CID 221577784.
Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA (June 2008). “Comparison of aspects of smoking among the four histological types of lung cancer”. 《Tobacco Control》 17 (3): 198–204. doi:10.1136/tc.2007.022582. PMC 3044470. PMID 18390646.
Liu X, Conner H, Kobayashi T, Kim H, Wen F, Abe S, 외. (August 2005). “Cigarette smoke extract induces DNA damage but not apoptosis in human bronchial epithelial cells”. 《American Journal of Respiratory Cell and Molecular Biology》 33 (2): 121–9. doi:10.1165/rcmb.2003-0341OC. PMID 15845867.
Herbst, Roy S.; Heymach, John V.; Lippman, Scott M. (2008년 9월 25일). “Lung Cancer”. 《New England Journal of Medicine》 359 (13): 1367–1380. doi:10.1056/NEJMra0802714. ISSN 0028-4793. PMID 18815398. S2CID 33554415.
Kastan MB (April 2008). “DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture”. 《Molecular Cancer Research》 6 (4): 517–24. doi:10.1158/1541-7786.MCR-08-0020. PMID 18403632.
O'Hagan HM, Mohammad HP, Baylin SB (August 2008). Lee JT, 편집. “Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island”. 《PLOS Genetics》 4 (8): e1000155. doi:10.1371/journal.pgen.1000155. PMC 2491723. PMID 18704159.
Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, 외. (July 2007). “DNA damage, homology-directed repair, and DNA methylation”. 《PLOS Genetics》 3 (7): e110. doi:10.1371/journal.pgen.0030110. PMC 1913100. PMID 17616978.
Harper JW, Elledge SJ (December 2007). “The DNA damage response: ten years after”. 《Molecular Cell》 28 (5): 739–45. doi:10.1016/j.molcel.2007.11.015. PMID 18082599.
Chawla M, Kumar R, Agarwala S, Bakhshi S, Gupta DK, Malhotra A (October 2010). “Role of positron emission tomography-computed tomography in staging and early chemotherapy response evaluation in children with neuroblastoma”. 《Indian Journal of Nuclear Medicine》 25 (4): 147–55. doi:10.4103/0972-3919.78249. PMC 3109821. PMID 21713223.
Dupuy DE, Shulman M (September 2010). “Current status of thermal ablation treatments for lung malignancies”. 《Seminars in Interventional Radiology》 27 (3): 268–75. doi:10.1055/s-0030-1261785. PMC 3324195. PMID 22550366.
Bargellini I, Bozzi E, Cioni R, Parentini B, Bartolozzi C (October 2011). “Radiofrequency ablation of lung tumours”. 《Insights into Imaging》 2 (5): 567–576. doi:10.1007/s13244-011-0110-7. PMC 3259330. PMID 22347976.
Kwan SW, Mortell KE, Talenfeld AD, Brunner MC (January 2014). “Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer”. 《Journal of Vascular and Interventional Radiology》 25 (1): 1–9.e1. doi:10.1016/j.jvir.2013.10.018. PMID 24365502.
Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE (July 2006). “Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer”. 《Journal of Vascular and Interventional Radiology》 17 (7): 1117–24. doi:10.1097/01.RVI.0000228373.58498.6E. PMID 16868164.
Vasconcellos, Vitor F.; Marta, Guilherme N.; da Silva, Edina Mk; Gois, Aecio Ft; de Castria, Tiago B.; Riera, Rachel (2020년 1월 13일). “Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer”. 《The Cochrane Database of Systematic Reviews》 1 (1): CD009256. doi:10.1002/14651858.CD009256.pub3. ISSN 1469-493X. PMC 6956680. PMID 31930743.
Ferrara, Roberto; Imbimbo, Martina; Malouf, Reem; Paget-Bailly, Sophie; Calais, François; Marchal, Corynne; Westeel, Virginie (2021년 4월 30일). “Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer”. 《Cochrane Database of Systematic Reviews》 2021 (4): CD013257. doi:10.1002/14651858.CD013257.pub3. PMC 8092423. PMID 33930176.
Yang ZY, Liu L, Mao C, Wu XY, Huang YF, Hu XF, Tang JL (November 2014). “Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer”. 《The Cochrane Database of Systematic Reviews》 (11): CD009948. doi:10.1002/14651858.CD009948.pub2. PMID 25400254.
Hirsch FR, Bunn PA (May 2009). “EGFR testing in lung cancer is ready for prime time”. 《The Lancet. Oncology》 10 (5): 432–3. doi:10.1016/s1470-2045(09)70110-x. PMID 19410185.
Kris MG (October 2005). “How today's developments in the treatment of non-small cell lung cancer will change tomorrow's standards of care”. 《The Oncologist》. 10 Suppl 2 (Suppl 2): 23–9. doi:10.1634/theoncologist.10-90002-23. PMID 16272456.
Sherwood J, Dearden S, Ratcliffe M, Walker J (September 2015). “Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review”. 《Journal of Experimental & Clinical Cancer Research》 34 (1): 92. doi:10.1186/s13046-015-0207-9. PMC 4559261. PMID 26338018.
Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, 외. (December 2006). “Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer”. 《The New England Journal of Medicine》 355 (24): 2542–50. doi:10.1056/nejmoa061884. PMID 17167137.
Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, 외. (November 2016). “Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer”. 《The New England Journal of Medicine》 375 (19): 1823–1833. doi:10.1056/NEJMoa1606774. PMID 27718847.
Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, 외. (March 2019). “Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater”. 《Journal of Clinical Oncology》 37 (7): 537–546. doi:10.1200/JCO.18.00149. PMID 30620668. S2CID 58640902.

semanticscholar.org

api.semanticscholar.org

Khajuria, Ocean; Sharma, Neha (2021년 12월 1일). “Epigenetic targeting for lung cancer treatment via CRISPR/Cas9 technology”. 《Advances in Cancer Biology - Metastasis》 (영어) 3: 100012. doi:10.1016/j.adcanc.2021.100012. ISSN 2667-3940. S2CID 241848193.
Travis WD, Travis LB, Devesa SS (January 1995). “Lung cancer”. 《Cancer》 75 (1 Suppl): 191–202. doi:10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y. PMID 8000996. S2CID 221577784.
Popper HH (2011). “Large cell carcinoma of the lung – a vanishing entity?”. 《Memo - Magazine of European Medical Oncology》 4: 4–9. doi:10.1007/s12254-011-0245-8. S2CID 71238993.
Khajuria, Ocean; Sharma, Neha (2021년 12월 1일). “Epigenetic targeting for lung cancer treatment via CRISPR/Cas9 technology”. 《Advances in Cancer Biology - Metastasis》 (영어) 3: 100012. doi:10.1016/j.adcanc.2021.100012. ISSN 2667-3940. S2CID 241848193.
Khajuria, Ocean; Sharma, Neha (2021년 12월 1일). “Epigenetic targeting for lung cancer treatment via CRISPR/Cas9 technology”. 《Advances in Cancer Biology - Metastasis》 (영어) 3: 100012. doi:10.1016/j.adcanc.2021.100012. ISSN 2667-3940. S2CID 241848193.
Herbst, Roy S.; Heymach, John V.; Lippman, Scott M. (2008년 9월 25일). “Lung Cancer”. 《New England Journal of Medicine》 359 (13): 1367–1380. doi:10.1056/NEJMra0802714. ISSN 0028-4793. PMID 18815398. S2CID 33554415.
Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, 외. (March 2019). “Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater”. 《Journal of Clinical Oncology》 37 (7): 537–546. doi:10.1200/JCO.18.00149. PMID 30620668. S2CID 58640902.

umm.edu

“Non-small cell lung cancer”. 《University of Maryland Medical Center》 (영어). 2017년 12월 4일에 확인함.

web.archive.org

“What Is Non-Small Cell Lung Cancer?”. 《www.cancer.org》. 2017년 1월 17일에 원본 문서에서 보존된 문서. 2023년 9월 13일에 확인함.
Travis, William D; Brambilla, Elisabeth; Muller-Hermelink, H Konrad; 외., 편집. (2004). 《Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart》 (PDF). World Health Organization Classification of Tumours. Lyon: IARC Press. ISBN 978-92-832-2418-1. 2009년 8월 23일에 원본 문서 (PDF)에서 보존된 문서. 2010년 3월 27일에 확인함.
“Non-Small Cell Lung Cancer Risk Factors”. 《www.cancer.org》. 2016년 12월 7일에 원본 문서에서 보존된 문서. 2023년 9월 13일에 확인함.
〈Cancer Staging Posters: Lung〉 (PDF). 《AJCC Cancer Staging》 7판. 2009. 2011년 9월 28일에 원본 문서 (PDF)에서 보존된 문서.
“Chemoembolisation”. Cancer Research UK. 2017년 8월 30일. 2007년 10월 9일에 원본 문서에서 보존된 문서.
“Lung Cancer online”. 《lungcanceronline.org》. 2008년 6월 17일에 원본 문서에서 보존된 문서. 2008년 12월 13일에 확인함.

wikimedia.org

commons.wikimedia.org

Smokers defined as current or former smoker of more than 1 year of duration. See image page in Commons for percentages in numbers. Reference: Table 2 in: Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA (June 2008). “Comparison of aspects of smoking among the four histological types of lung cancer”. 《Tobacco Control》 17 (3): 198–204. doi:10.1136/tc.2007.022582. PMC 3044470. PMID 18390646.

worldcat.org

Khajuria, Ocean; Sharma, Neha (2021년 12월 1일). “Epigenetic targeting for lung cancer treatment via CRISPR/Cas9 technology”. 《Advances in Cancer Biology - Metastasis》 (영어) 3: 100012. doi:10.1016/j.adcanc.2021.100012. ISSN 2667-3940. S2CID 241848193.
Khajuria, Ocean; Sharma, Neha (2021년 12월 1일). “Epigenetic targeting for lung cancer treatment via CRISPR/Cas9 technology”. 《Advances in Cancer Biology - Metastasis》 (영어) 3: 100012. doi:10.1016/j.adcanc.2021.100012. ISSN 2667-3940. S2CID 241848193.
Khajuria, Ocean; Sharma, Neha (2021년 12월 1일). “Epigenetic targeting for lung cancer treatment via CRISPR/Cas9 technology”. 《Advances in Cancer Biology - Metastasis》 (영어) 3: 100012. doi:10.1016/j.adcanc.2021.100012. ISSN 2667-3940. S2CID 241848193.
Herbst, Roy S.; Heymach, John V.; Lippman, Scott M. (2008년 9월 25일). “Lung Cancer”. 《New England Journal of Medicine》 359 (13): 1367–1380. doi:10.1056/NEJMra0802714. ISSN 0028-4793. PMID 18815398. S2CID 33554415.
Vasconcellos, Vitor F.; Marta, Guilherme N.; da Silva, Edina Mk; Gois, Aecio Ft; de Castria, Tiago B.; Riera, Rachel (2020년 1월 13일). “Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer”. 《The Cochrane Database of Systematic Reviews》 1 (1): CD009256. doi:10.1002/14651858.CD009256.pub3. ISSN 1469-493X. PMC 6956680. PMID 31930743.